- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 15, 2026 | 85.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 85.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 92.08M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $75.05M |
| Capex | Q1 2026 · Mar 31, 2026 | $6.72M |
| Capex | Q1 2026 · Mar 31, 2025 | $8.11M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$47.96M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$31.16M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $59.32M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $90.57M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $847.9M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $982.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.31B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.32B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.66B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.66B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.96B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.98B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.70 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.70 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $52.96M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $57.68M |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | $64.04M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $5.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $76.89M |
| Revenue | Q1 2026 · Mar 31, 2026 | $521.39M |
| Revenue | Q1 2026 · Mar 31, 2025 | $740.93M |